[63] [51] Clinical trials and early approvals for diabetes [edit] In June 2008, a phase II clinical trial began studying semaglutide, a once-weekly diabetes therapy as a longer-acting alternative to liraglutide
Boxed warning (FDA): Monitor for increased suicidal thoughts in younger people, especially during dose changes
Lilly's Kinsale facility, recognised as ISPE's 2024 Overall Facility of the Year, uses a hybrid SPPS/LPPS platform in which SPPS builds pre-assembled peptide fragments of six to fourteen amino acids, and liquid-phase peptide synthesis (LPPS) then couples those fragments together using continuous processing, with parallel fragment production at multiple global supply nodes creating supply chain resilience that purely centralised batch manufacturing cannot provide
The ruling allows plaintiffs to continue relying on expert testimony concerning delayed gastric emptying, gastrointestinal complications, adequacy of warning labels, and alleged deficiencies in safety analyses submitted to the FDA
GLP-1 RAs can also influence the autonomic nervous system, although the net impact on BP is complex
By aligning key protocol components and analytic frameworks with those of SUSTAIN-6 and SURPASS-CVOT, we produced self-critical evidence that allowed us to directly benchmark results against reference trials to inform subsequent analyses in expanded populations